In a report released today, Matthew Biegler from Oppenheimer reiterated a Buy rating on Gilead Sciences (GILD – Research Report), with a price ...

Fintel reports that on February 11, 2025, Oppenheimer initiated coverage of International Business Machines (NYSE:IBM) with a ...

Tesla (TSLA) is advancing 3% after investment bank Benchmark started coverage of the automaker with a Buy rating.

Analysts at Oppenheimer said in a research note on Tuesday that billionaire Elon Musk's recent bid for ChatGPT parent OpenAI ...

Oppenheimer reiterated its Outperform rating and $115.00 price target for Gilead Sciences (NASDAQ:GILD) stock, following a strong fourth-quarter performance that surpassed consensus estimates. Gilead ...

December, making it the worst performer among the top stocks. Investors are concerned about CEO Elon Musk's political ...

OpenAI was cofounded by Musk and Altman in 2018 as a non-profit, with Musk leaving before the company took off. Musk’s ...

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “market perform” rating restated by analysts at Oppenheimer in a research note issued to investors on Monday, MarketBeat.com reports ...

At its current pre-market price, Tesla's stock is down 33% since hitting a record high on Dec. 18, 2024, weeks after the ...

In the eyes of Tesla shareholders, Elon Musk hardly needed another distraction. OpenAI could turn out to be a costly one.

Presenters have been revealed for the 2025 Academy Awards. The first batch includes last year's lead acting winners Cillian ...

One very rare Singer DLS will be auctioned off by RM Sotheby’s this month and is expected to sell for between $3.25 million ...